Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2020-D-1079
Documents
1
Total comments
7
all analyzed
Comment status
Open
Last activity
Jun 22, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherJan 24, 2023
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry - Final GuidanceNo comment period💬 7 comments